Types of PCOS: Real Phenotypes vs Social Media Labels
Learn the real types of PCOS: four Rotterdam phenotypes built from androgens, ovulation and ovary appearance, and what viral labels do and do not mean.

On this page
- Are there really four types of PCOS?
- What are the Rotterdam phenotypes A, B, C and D?
- What the research says about the four types
- What is adrenal PCOS, and is it a real type?
- Is inflammatory PCOS a separate type?
- What does insulin-resistant PCOS mean?
- Is post-pill PCOS a real diagnosis?
- How to sort out your pattern: a step-by-step checklist
- How do doctors confirm the diagnosis?
- Will the new PMOS name change the types?
- Does the type change treatment?
- When to see a doctor
- Regional notes
- Frequently asked questions
- The bottom line
The types of PCOS that research recognizes are four phenotypes, labeled A to D, that follow from the Rotterdam diagnostic criteria. Each is a combination of three features: high androgens, irregular ovulation and polycystic-looking ovaries on ultrasound. Social media adds labels such as adrenal, inflammatory and post-pill PCOS. None of these is a diagnostic category in the Rotterdam criteria or the 2023 International guideline.
Polycystic ovary syndrome (PCOS): a common hormonal condition in which ovulation becomes irregular, androgens (male-type hormones such as testosterone) run higher than typical, and the body often handles insulin less efficiently. In 2026, a Lancet consensus proposed a new name, polyendocrine metabolic ovarian syndrome (PMOS), with a three-year transition. This article uses PCOS because most guidelines and search habits still do.
Key takeaways
- The Rotterdam consensus, published in Human Reproduction in 2004, diagnoses PCOS when two of three features are present after other causes are excluded: high androgens, irregular ovulation, or polycystic ovarian morphology.
- Those three features combine into four phenotypes. Phenotype A has all three, B has androgens and irregular ovulation, C has androgens and polycystic-looking ovaries, and D has irregular ovulation and polycystic-looking ovaries without androgen excess.
- According to the International Evidence-based PCOS Guideline 2023, polycystic ovarian morphology means 20 or more follicles per ovary on a modern transvaginal scan and/or an ovarian volume of 10 mL or more.
- According to the WHO PCOS fact sheet, an estimated 10 to 13 percent of women of reproductive age are affected, and up to 70 percent of those affected are undiagnosed.
- Labels such as adrenal, inflammatory and post-pill PCOS describe possible contributors or symptom patterns. They are not recognized diagnostic types, and each still needs the same clinical assessment.
- Phenotype matters for understanding your pattern, but treatment decisions depend mainly on the features you have, such as irregular cycles, acne or excess hair growth, and blood sugar or weight-related risk.
Are there really four types of PCOS?
Yes, in the research sense. Researchers and clinicians recognize four phenotypes, labeled A, B, C and D. A phenotype is a pattern of features, not a separate disease. Two people can both have PCOS and still show different patterns, and the pattern helps your clinician decide which tests to order and which options to discuss.
The Rotterdam consensus, published in Human Reproduction in 2004, set the diagnostic approach that most of the world still uses. According to that consensus, PCOS is diagnosed when two of three features are present and other causes have been excluded. The features are high androgens, which can show up as clinical signs such as acne or excess hair growth, or as raised androgen levels in a blood test. Irregular ovulation means cycles that are infrequent, unpredictable or absent. Polycystic ovarian morphology (PCOM) describes an ovary appearance on ultrasound. The four phenotypes come directly from combining these three features. The A to D labels became standard after a 2012 U.S. National Institutes of Health (NIH) workshop recommended that the specific phenotype be identified in research.
Where the "four types" idea comes from
Most people who search for the types of PCOS are trying to make sense of short social media videos. Those videos often describe "adrenal PCOS", "inflammatory PCOS", "insulin-resistant PCOS" and "post-pill PCOS" as separate kinds of the condition. Some of these labels point to real science, such as the role of insulin or of the adrenal glands. Others describe a symptom pattern that a clinician would simply investigate.
The confusion has a simple cause. The Rotterdam phenotypes are called types, and so are the social media labels. Only the Rotterdam phenotypes are defined by a published diagnostic framework. The rest of this article separates the two, so you can see which claims have evidence behind them and which need more research.
How the four phenotypes compare
The table below summarizes the Rotterdam phenotypes. It describes patterns, not treatment rules.
| Phenotype | High androgens | Irregular ovulation | Polycystic ovarian morphology | What the pattern usually looks like |
|---|---|---|---|---|
| A | Yes | Yes | Yes | The classic, "full" pattern, with all three features |
| B | Yes | Yes | No | Androgen signs and irregular cycles, with ovaries that look typical on ultrasound |
| C | Yes | No | Yes | Androgen signs and polycystic-looking ovaries, with cycles that stay regular |
| D | No | Yes | Yes | Irregular cycles and polycystic-looking ovaries, without clinical or blood-test androgen excess |
The table shows why the phenotypes matter. A person with phenotype C may have regular periods and still meet the diagnostic rules, because androgen signs and ovary appearance are enough when combined. A person with phenotype D may have no acne or hair changes at all, which is one reason the pattern is often missed.
What are the Rotterdam phenotypes A, B, C and D?
Each phenotype reflects a different balance of the same underlying hormone and ovary changes. Understanding the pattern makes it easier to explain your symptoms to a clinician. The sections below describe what each phenotype looks like, why it happens in plain language, and what you can do next.
Phenotype A: all three features
Phenotype A is the pattern most people picture when they hear PCOS. It combines high androgens, irregular ovulation and polycystic-looking ovaries. Irregular ovulation means cycles can be long, short or missed, which makes it hard to predict when you will ovulate. Androgen excess may show up as acne along the jaw, hair growth on the face, chest or abdomen, or thinning hair on the scalp.
The "why" is a chain of hormone signals. In many people with PCOS, the ovaries contain many small follicles, the fluid-filled sacs that hold developing eggs, and these follicles often do not mature fully. Without a clear mid-cycle surge, ovulation becomes irregular. The ovaries and adrenal glands can also produce more androgens, and high androgens can further disrupt follicle growth. The WHO fact sheet describes PCOS as a common hormonal disorder that affects ovulation and androgen levels, which is the broad picture that the phenotypes refine.
What you can do is start a simple cycle record for several months, noting the first day of each period and any acne or hair changes. This gives your clinician a longer timeline than a single visit can provide.
Phenotype B: androgens and irregular ovulation
Phenotype B has high androgens and irregular ovulation, but the ovaries do not show the polycystic pattern on ultrasound. This is an important point for readers who were told their scan was normal. Under the Rotterdam rules, ultrasound is only one of three features. A normal-looking ovary does not rule out PCOS if androgen signs and irregular cycles are present and other causes have been excluded.
Phenotype B is also a reason to ask about blood tests and symptom history, not just scans. The ovary appearance may change with age, weight, and the timing of the scan, so a single image is not the final word. The practical step is to bring your cycle record and a list of androgen symptoms to the appointment, so the pattern is visible even if the scan is not.
Phenotype C: androgens and polycystic-looking ovaries
Phenotype C combines high androgens with polycystic-looking ovaries, while cycles remain regular. This pattern is easy to miss because regular periods are often assumed to mean normal hormones. Under the Rotterdam framework, regular cycles do not exclude PCOS when the other two features are present.
Phenotype C is also where many people first notice acne or unwanted hair growth in their twenties or thirties and assume it is a skin problem. A clinician who asks about the full symptom pattern, including cycle regularity and ovary findings, can often give a clearer answer. Keeping a symptom diary, including skin and hair changes, is useful for this reason.
Phenotype D: irregular ovulation and polycystic-looking ovaries
Phenotype D is the pattern without clinical or blood-test androgen excess. It combines irregular ovulation with polycystic-looking ovaries. Because androgen signs are absent, the pattern can be overlooked, and some people go years with cycle problems before it is investigated.
Some researchers have questioned whether phenotype D should count as PCOS or be treated as a separate pattern, and the debate is still active. Older definitions, such as the 1990 NIH criteria and the 2006 Androgen Excess and PCOS Society criteria, require androgen excess, so they do not include phenotype D. Studies comparing phenotypes have generally found that phenotype D has a milder metabolic profile than phenotypes A and B. For you as a reader, the practical message is that irregular periods and a polycystic-looking ovary on ultrasound are worth investigating even if your skin and hair look normal.
What the research says about the four types
This section names the sources behind the phenotypes and separates well-supported claims from open questions. The strength of each claim is stated so you can judge it.
The Rotterdam consensus (2004). The Rotterdam ESHRE/ASRM-sponsored workshop group defined the two-of-three diagnostic approach in Human Reproduction, which allows the four phenotype combinations. The approach has been the standard for more than two decades, so the evidence for the diagnostic framework is strong. The evidence that the phenotypes predict different treatment outcomes is much more limited, and researchers still debate it.
The International Evidence-based PCOS Guideline 2023. This Monash-led guideline sets the thresholds clinicians use today. It defines irregular cycles in adults as cycles shorter than 21 days or longer than 35 days, or fewer than 8 cycles a year, measured more than three years after the first period. It defines polycystic ovarian morphology as 20 or more follicles per ovary on a modern transvaginal scan and/or an ovarian volume of 10 mL or more. It also advises against using ultrasound for diagnosis within 8 years of the first period, and it does not recommend AMH testing for diagnosis in adolescents. Those specifics matter for the phenotype question, because the ovary feature is only one part of the picture.
The Lancet consensus (Teede et al., 2026). A global consensus process proposed the name polyendocrine metabolic ovarian syndrome (PMOS) for the condition. It recommends a three-year transition from the old name and says integration into international guidelines is planned in upcoming updates. The name change does not remove the phenotype framework from the research, but it does shift attention toward the metabolic and hormonal whole-body picture.
The WHO PCOS fact sheet. The WHO estimates that 10 to 13 percent of women of reproductive age are affected, and that up to 70 percent of affected women are undiagnosed. These figures give context for why a clear understanding of patterns matters.
The adrenal, inflammatory, insulin-resistant and post-pill labels. The evidence for these as separate, named types is limited. Research on insulin resistance and inflammation in PCOS is substantial, but the findings do not establish these as distinct diagnostic categories. The sections below explain what each label gets right and what it gets wrong.
What is adrenal PCOS, and is it a real type?
The adrenal glands sit above the kidneys and produce androgens alongside the ovaries. In many women with PCOS, the adrenal glands contribute some of the androgen excess, and some blood tests measure adrenal-origin androgens such as DHEA-S. This is why the adrenal glands appear in PCOS conversations.
The problem is the leap from "adrenals contribute to androgens" to "adrenal PCOS is a separate type." The Rotterdam criteria require that other causes of high androgens be excluded first. Those other causes include conditions such as non-classic congenital adrenal hyperplasia, a genetic form of adrenal enzyme deficiency, and rare androgen-producing tumors. Testing for these is part of a proper PCOS workup, not a separate diagnosis.
The evidence for a distinct "adrenal PCOS" type is limited. What the evidence supports is that the adrenal and ovarian sources of androgens should be considered together when a clinician evaluates high androgen levels. The figure below shows the two sources and the causes that must be excluded.
What you can do: if your androgen symptoms started suddenly, became severe quickly, or appeared with other unusual signs, say so at your appointment. Your clinician can decide whether further testing is needed.
Is inflammatory PCOS a separate type?
Inflammation is the body's immune response, and some researchers have measured inflammatory markers in women with PCOS. Some studies have reported higher levels in women with PCOS than in comparison groups, but results vary across studies. Weight, sleep, diet and insulin resistance can all influence these markers, so it is hard to isolate PCOS itself as the cause.
The label "inflammatory PCOS" therefore describes a research question, not a diagnosis. There is no test that defines an inflammatory type, and no treatment is recognized specifically for it. The evidence is limited, and anyone promoting an inflammation-based subtype should be asked for the study behind the claim.
What you can do is focus on the parts of inflammation advice that are well-supported in general health: regular physical activity, adequate sleep, and a dietary pattern rich in vegetables, fiber and whole foods. These help blood sugar, weight and general health, which are the things that matter most in PCOS, whether or not inflammation is part of your pattern. Our pillar article on PCOS symptoms and diagnosis covers the core features your clinician will assess.
What does insulin-resistant PCOS mean?
Insulin resistance means the body's cells respond less well to insulin, the hormone that moves sugar from the blood into cells. To compensate, the pancreas makes more insulin. High insulin levels then act on the ovaries and stimulate them to make more androgens, which can disrupt ovulation. This cycle is one of the best-supported links in PCOS, and it explains why blood sugar and weight-related risk are central to the condition. The diagram below shows the loop.
Insulin resistance is common in PCOS across phenotypes, and it is not limited to people who carry extra weight. The CDC's page on PCOS and diabetes explains why women with PCOS are at higher risk of type 2 diabetes. Endocrinologists, the hormone specialists who manage this work-up, are represented by the Endocrine Society. The 2023 International guideline recommends that glycemic status (blood sugar) be assessed at diagnosis in all adults and adolescents with PCOS and rechecked every one to three years depending on risk. It also says that insulin blood tests are of limited clinical relevance and should not be used in routine care, so your clinician checks blood sugar markers rather than measuring insulin resistance directly. The guideline lists lifestyle changes as the first step and includes medications that may be considered alongside them.
It is worth being clear about the limits. Insulin resistance is a metabolic feature that often accompanies PCOS, but it is not a separate type of the condition. A person with phenotype C, for example, can have insulin resistance and regular cycles. Treating insulin resistance can help some symptoms, but the evidence for each drug varies, and decisions should be made with a clinician.
Lean women and insulin resistance
Some people with PCOS have a normal body weight but still show insulin resistance and androgen signs. This group is often under-recognized, because the weight-based picture of PCOS is so common in public messaging. Insulin resistance can exist at any body size, and a normal weight does not rule out PCOS. Our article on lean PCOS explains how the diagnosis and treatment differ for this group.
Is post-pill PCOS a real diagnosis?
"Post-pill PCOS" is the label for symptoms that appear or seem to get worse after stopping hormonal birth control, such as the combined pill, the patch or the ring. The idea is that the pill was hiding a pre-existing pattern, and stopping it revealed PCOS. Some of this is plausible, because hormonal contraception suppresses ovulation and lowers androgen production while it is taken, which can mask signs that would otherwise show up.
Fertility usually returns quickly after stopping the pill, patch or ring. Quick return of fertility is not the same as quick return of regular cycles, though. Cycles can take several months to settle, and that delay is common. The CDC's contraception and birth control methods page explains how each method works and is a reliable place to check the basics.
The important point is that "post-pill PCOS" is not a diagnostic category. What matters is whether the pattern persists after the hormones have cleared your system. If your cycles remain irregular for several months after stopping, or you have androgen signs that do not settle, the question becomes the same one a clinician would ask anyone: does the full pattern meet the diagnostic rules?
Illustrative example: a 27-year-old stops the pill to try for a pregnancy and finds her cycles are 45 days long for eight months. She has acne along her jaw that started when she was a teenager and was controlled by the pill. Her clinician would ask about her cycles, androgen signs and ovary findings, not the label. The question is whether she meets the criteria, not whether the pill caused a "post-pill" type.
How to sort out your pattern: a step-by-step checklist
Before an appointment, you can organize what you already know. The steps below mirror the questions a clinician will ask, and they make the visit more efficient.
- Track your cycles for several months. Note the first day of each period, the length of each cycle and any missed or unusually short cycles. The 2023 guideline counts cycles shorter than 21 days, longer than 35 days, or fewer than 8 cycles a year as irregular in adults.
- Record androgen signs. Note acne, hair growth on the face, chest or abdomen, and scalp hair thinning. Take photos if that helps you track changes over time.
- Note any change since stopping hormonal birth control. Write down the date you stopped, the method you used and how your cycles have changed since then.
- Record metabolic and general symptoms. Note fatigue, sleep changes, weight changes, cravings and any family history of diabetes or PCOS.
- Bring the list to your clinician. Ask which tests are needed to exclude other causes of high androgens and whether an ultrasound is appropriate for your age and history.
- Ask how the result affects your plan. Ask which features are driving your treatment choices, and what would change the plan later.
- Re-check the pattern over time. Patterns can change with age, weight, pregnancy plans and medication, so a diagnosis made once may need review.
Keeping the record in one place makes steps one to four much easier. A tracker like Shebalance lets you log cycle days and symptoms in a few taps, and its trends view shows what is changing.
Try it
Logging your cycle days and symptoms in one tap gives you a dated record that shows whether your pattern is stable or changing. Open Shebalance
How do doctors confirm the diagnosis?
Diagnosis is a clinical process, not a single test. A clinician first excludes other conditions that can cause the same symptoms, such as thyroid disease, high prolactin and, where relevant, the adrenal conditions described above. Then they check the three Rotterdam features. Two of the three must be present for a PCOS diagnosis.
Blood tests usually measure androgen levels and sometimes other hormones. Blood sugar markers may also be checked, because insulin resistance is common in PCOS. The International guideline sets timing rules that matter for ultrasound. It advises against using ultrasound to diagnose PCOS within 8 years of the first period, because ovary appearance in the years after puberty can look polycystic in people who do not have PCOS. It also advises against AMH testing for diagnosis in adolescents, so a teenager's pattern is usually assessed through cycles and clinical signs.
Ask your clinician which assessments apply to your age and history. A good appointment ends with a clear summary of what was checked, what was excluded and what the working diagnosis is, along with a plan for review.
Will the new PMOS name change the types?
In 2026, the Lancet consensus proposed renaming PCOS to polyendocrine metabolic ovarian syndrome (PMOS). The name reflects that the condition involves more than the ovaries, including insulin, androgens and other hormone systems. The consensus proposes a three-year transition period, and it says the new name will be integrated into international guidelines in future updates. Our article on the PMOS name change covers what the change means for diagnosis and care.
The rename does not replace the Rotterdam phenotypes or remove the four patterns from the research. What it changes is how clinicians and patients talk about the condition. A wider name may make it easier to take insulin, metabolic health and mental health seriously, rather than treating PCOS only as a fertility or appearance problem. Patterns still matter, and the same features still guide assessment.
If you already have a PCOS diagnosis, you do not need to re-diagnose yourself under the new name. Your clinician will explain how any change applies to your care.
Does the type change treatment?
Treatment is chosen by the features you have, not by the letter of a phenotype. The 2023 guideline recommends a lifestyle foundation for everyone with PCOS, including regular physical activity and nutrition advice tailored to the person. Beyond lifestyle, the choice depends on your goals. Cycle regulation, androgen-related skin and hair changes, blood sugar, weight-related risk and fertility plans each point toward different options.
For adults who do not want pregnancy, the guideline says the combined oral contraceptive pill could be recommended for excess hair growth (hirsutism) and/or irregular cycles, with no specific pill type preferred and the lowest effective estrogen dose considered. It says metformin should be considered for adults with a BMI of 25 or more for weight and metabolic outcomes, including insulin resistance, glucose and cholesterol, and may be considered at a lower BMI, acknowledging limited evidence. It also lists anti-obesity medicines, including liraglutide and semaglutide, as options that could be considered alongside lifestyle changes. Their use for PCOS is off-label in most countries, and neither was studied specifically in PCOS in the trials that led to their weight-management approvals. Any of these choices should be made with a clinician who knows your full history.
The practical takeaway is that your pattern guides which features need attention first. A person with phenotype D and irregular cycles may focus on cycle regulation. A person with phenotype A and high androgen signs may need attention to skin, hair and blood sugar. The sections on pregnancy-planning and irregular periods cover the options for those specific goals.
Our tracker, Shebalance, can produce a doctor-ready PDF that summarizes your cycles and symptoms. That document is the kind of record that helps a clinician decide which features to act on.
When to see a doctor
Most PCOS patterns are managed over time in routine care. Some symptoms need urgent attention and should not wait for a scheduled appointment.
Get urgent care if you notice
- Bleeding that soaks through a pad or tampon every hour for several hours, or bleeding with dizziness or fainting.
- Bleeding after menopause, or any new bleeding after months without a period.
- Signs of a blood clot, such as one leg that is swollen, painful or warm, or sudden chest pain or shortness of breath.
- Severe pelvic or abdominal pain, especially with fever or vomiting.
- Thoughts of ending your life or of self-harm. Contact your local emergency number or a crisis line now, and tell someone you trust that you need help.
Regional notes
United States. The CDC's PCOS and diabetes page explains the metabolic side of the condition, the NICHD's PCOS topic page covers research and diagnosis, and the Office on Women's Health provides a PCOS overview. ACOG's patient FAQs can help you prepare for a gynecology appointment. Talk to a board-certified obstetrician-gynecologist or an endocrinologist if your symptoms are complex. For plain-language background, Mayo Clinic publishes patient education on hormone conditions.
United Kingdom. The NHS's PCOS page gives the current advice on diagnosis and management, and it is the place to start for a referral in England, Wales, Scotland or Northern Ireland. The NHS sets out when to see a GP and what tests to expect. Local services vary, so ask your GP how referrals to endocrine or gynecology teams work where you live.
European Union and Australia. The International Evidence-based PCOS Guideline 2023, developed through a Monash University process in Australia, is the most detailed international reference for diagnosis and management. National health systems in the EU use their own referral routes, so your primary care doctor is the right first contact. The WHO fact sheet provides the global prevalence figures used across these regions.
South Asia and the Middle East. The WHO estimate of 10 to 13 percent prevalence applies globally, and PCOS is recognized across South Asia and the Middle East, where awareness and access to testing vary. Your national health ministry and local endocrinology or gynecology services are the best sources for local referral pathways. Ask about access to androgen testing and blood sugar checks before you book a visit.
Frequently asked questions
Are there really four types of PCOS?
Yes, in the research sense. The Rotterdam criteria, published in Human Reproduction in 2004, allow four phenotypes, labeled A to D, built from high androgens, irregular ovulation and polycystic-looking ovaries. They are patterns of features within one condition, not four separate diseases. Social media labels such as adrenal or inflammatory PCOS are not recognized diagnostic types. Your clinician will assess which features you have and explain what that means for your care.
Is adrenal PCOS a real diagnosis?
Adrenal glands contribute some androgens in many women with PCOS, so they are part of the picture. However, "adrenal PCOS" is not a separate diagnosis. The Rotterdam criteria require that other causes of high androgens, including non-classic congenital adrenal hyperplasia and rare androgen-producing tumors, be excluded first. If your androgen levels are very high or came on suddenly, your clinician may order further tests to rule these out.
What does inflammatory PCOS mean?
Inflammatory PCOS refers to research on inflammatory markers in women with PCOS. Some studies report higher levels, but results vary, and weight, sleep and insulin resistance also affect these markers. There is no recognized test or treatment for an inflammatory type. The most useful steps are the general ones: regular activity, good sleep, and a diet built around vegetables, fiber and whole foods.
Can you have PCOS with regular periods?
Yes. Under the Rotterdam criteria, regular cycles do not rule out PCOS. Phenotype C combines androgen signs and polycystic-looking ovaries with regular cycles. The International guideline defines irregular cycles precisely, so a clinician can check whether your cycles fall outside the normal range. If you have androgen symptoms or ovary findings, regular periods alone do not settle the question.
Does post-pill PCOS exist?
"Post-pill PCOS" is not a diagnostic type. Hormonal contraception can suppress ovulation and hide androgen signs while it is used, so some people notice symptoms after stopping. Fertility usually returns quickly after stopping the pill, patch or ring, but cycles may take several months to settle. If irregular cycles or androgen signs persist, the usual Rotterdam assessment applies.
Which type of PCOS is the most serious?
Studies generally find higher metabolic risk, such as insulin resistance, in phenotypes A and B, which combine high androgens with irregular ovulation, and a milder profile in phenotype D. Individual risk still varies, so blood sugar, blood pressure, cholesterol and weight-related risk are assessed for every person with PCOS, whatever the phenotype. Ask your clinician which risks apply to you.
Do I need an ultrasound to be diagnosed?
Not always. Ultrasound is one of three Rotterdam features, and the International guideline advises against using it to diagnose PCOS within 8 years of the first period. A diagnosis can be made when two of the three features are present, so high androgens and irregular ovulation can be enough. Your clinician will decide whether a scan is useful for your age and history.
Can my PCOS type change over time?
Your pattern can change. Weight changes, pregnancy, hormonal medication and age can all alter cycles, androgen signs and ovary appearance. This is why a diagnosis may be reviewed at different life stages. Keeping a dated record of your cycles and symptoms helps your clinician see whether the pattern is stable, improving or changing.
The bottom line
The types of PCOS that research recognizes are four Rotterdam phenotypes, A to D, built from high androgens, irregular ovulation and polycystic-looking ovaries. Adrenal, inflammatory, insulin-resistant and post-pill labels describe possible contributors or patterns, not diagnostic types. Other causes of high androgens must be excluded first, and treatment depends on the features you have rather than on a letter. Start with a clear record of your cycles and symptoms, and ask your clinician which features matter most for your plan. To keep that record, Shebalance on Google Play is free, needs no account and keeps your data on your device.
Medical disclaimer
This article is for education only and is not medical advice. It does not diagnose, treat or prevent any condition. PCOS diagnosis and treatment depend on your personal history and examination, so talk with a qualified clinician before making decisions about medication, contraception or lifestyle changes. Shebalance is a symptom and cycle tracker. It is not a diagnostic tool and does not replace a clinician.
References
- Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026. https://doi.org/10.1016/S0140-6736(26)00717-8
- Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction. 2004;19(1):41-47. https://doi.org/10.1093/humrep/deh098
- International Evidence-based PCOS Guideline. Monash University, 2023. https://www.monash.edu/medicine/mchri/pcos/guideline
- World Health Organization. Polycystic ovary syndrome fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
- Centers for Disease Control and Prevention. Contraception and Birth Control Methods, dated August 6, 2024. https://www.cdc.gov/contraception/about/index.html
- Centers for Disease Control and Prevention. Polycystic Ovary Syndrome (PCOS) and Diabetes. https://www.cdc.gov/diabetes/risk-factors/pcos-polycystic-ovary-syndrome.html
- Eunice Kennedy Shriver National Institute of Child Health and Human Development. Polycystic Ovary Syndrome. https://www.nichd.nih.gov/health/topics/pcos
- NHS. Polycystic ovary syndrome (PCOS). https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/
- Office on Women's Health. Polycystic Ovary Syndrome. https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
- American College of Obstetricians and Gynecologists. Patient FAQs. https://www.acog.org/womens-health/faqs
- National Institutes of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome: Final Report. 2012. [VERIFY LINK]
Shebalance
Track PCOS and menopause symptoms privately: one-tap logs, weekly trends and a doctor-ready PDF. Free, no account.